Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: Physicochemical Characterization.

Sun D, Rouse R, Patel V, Wu Y, Zheng J, Karmakar A, Patri AK, Chitranshi P, Keire D, Ma J, Jiang W.

Nanomaterials (Basel). 2018 Jan 5;8(1). pii: E25. doi: 10.3390/nano8010025.

2.

Investigating the susceptibility of mice to a bacterial challenge after intravenous exposure to durable nanoparticles.

Khan S, Zhang Q, Marasa BS, Sung K, Cerniglia CE, Ingle T, Jones MY, Paredes AM, Tobin GA, Bancos S, Weaver JL, Goering PL, Howard PC, Patri AK, Tyner KM.

Nanomedicine (Lond). 2017 Sep;12(17):2097-2111. doi: 10.2217/nnm-2017-0176. Epub 2017 Aug 14.

PMID:
28805153
3.

Repetitive Application of Sunscreen Containing Titanium Dioxide Nanoparticles on Human Skin.

Coelho SG, Patri AK, Wokovich AM, McNeil SE, Howard PC, Miller SA.

JAMA Dermatol. 2016 Apr;152(4):470-2. doi: 10.1001/jamadermatol.2015.5944. No abstract available.

PMID:
26913928
4.

Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles.

Dobrovolskaia MA, Neun BW, Man S, Ye X, Hansen M, Patri AK, Crist RM, McNeil SE.

Nanomedicine. 2014 Oct;10(7):1453-63. doi: 10.1016/j.nano.2014.01.009. Epub 2014 Feb 7.

5.

Assessing the barriers to image-guided drug delivery.

Lanza GM, Moonen C, Baker JR Jr, Chang E, Cheng Z, Grodzinski P, Ferrara K, Hynynen K, Kelloff G, Lee YE, Patri AK, Sept D, Schnitzer JE, Wood BJ, Zhang M, Zheng G, Farahani K.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Jan-Feb;6(1):1-14. doi: 10.1002/wnan.1247. Epub 2013 Oct 31. Review.

6.

Inhibition of phosphoinositol 3 kinase contributes to nanoparticle-mediated exaggeration of endotoxin-induced leukocyte procoagulant activity.

Ilinskaya AN, Man S, Patri AK, Clogston JD, Crist RM, Cachau RE, McNeil SE, Dobrovolskaia MA.

Nanomedicine (Lond). 2014 Jul;9(9):1311-26. doi: 10.2217/nnm.13.137. Epub 2013 Nov 27.

7.

Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.

Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S, Dai RM, Kiu H, Cardone M, Naik S, Patri AK, Wang E, Marincola FM, Frank KM, Belkaid Y, Trinchieri G, Goldszmid RS.

Science. 2013 Nov 22;342(6161):967-70. doi: 10.1126/science.1240527.

8.

A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.

Adiseshaiah P, Dellinger A, MacFarland D, Stern S, Dobrovolskaia M, Ileva L, Patri AK, Bernardo M, Brooks DB, Zhou Z, McNeil S, Kepley C.

Invest Radiol. 2013 Nov;48(11):745-54. doi: 10.1097/RLI.0b013e318294de5d.

PMID:
23748228
9.

Biotargeted nanomedicines for cancer: six tenets before you begin.

Goldberg MS, Hook SS, Wang AZ, Bulte JW, Patri AK, Uckun FM, Cryns VL, Hanes J, Akin D, Hall JB, Gharkholo N, Mumper RJ.

Nanomedicine (Lond). 2013 Feb;8(2):299-308. doi: 10.2217/nnm.13.3.

10.

Challenges and opportunities in the advancement of nanomedicines.

Wei A, Mehtala JG, Patri AK.

J Control Release. 2012 Dec 10;164(2):236-46. doi: 10.1016/j.jconrel.2012.10.007. Epub 2012 Oct 12.

11.

Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory.

Crist RM, Grossman JH, Patri AK, Stern ST, Dobrovolskaia MA, Adiseshaiah PP, Clogston JD, McNeil SE.

Integr Biol (Camb). 2013 Jan;5(1):66-73. doi: 10.1039/c2ib20117h.

12.

Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance.

Zamboni WC, Torchilin V, Patri AK, Hrkach J, Stern S, Lee R, Nel A, Panaro NJ, Grodzinski P.

Clin Cancer Res. 2012 Jun 15;18(12):3229-41. doi: 10.1158/1078-0432.CCR-11-2938. Epub 2012 Jun 5. Review.

13.

Biological applications of dendrimers.

Patri AK, Simanek E.

Mol Pharm. 2012 Mar 5;9(3):341. doi: 10.1021/mp300057m. No abstract available.

PMID:
22384975
14.

Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro.

Dobrovolskaia MA, Patri AK, Simak J, Hall JB, Semberova J, De Paoli Lacerda SH, McNeil SE.

Mol Pharm. 2012 Mar 5;9(3):382-93. doi: 10.1021/mp200463e. Epub 2011 Nov 10.

15.

Sterilization of Silver Nanoparticles Using Standard Gamma Irradiation Procedure Affects Particle Integrity and Biocompatibility.

Zheng J, Clogston JD, Patri AK, Dobrovolskaia MA, McNeil SE.

J Nanomed Nanotechnol. 2011 Oct 25;2011(Suppl 5):001.

16.

Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge.

Dobrovolskaia MA, Patri AK, Potter TM, Rodriguez JC, Hall JB, McNeil SE.

Nanomedicine (Lond). 2012 Feb;7(2):245-56. doi: 10.2217/nnm.11.105. Epub 2011 Sep 30.

PMID:
21957862
17.

Newkome-type dendron stabilized gold nanoparticles: Synthesis, reactivity, and stability.

Cho TJ, Zangmeister RA, Maccuspie RI, Patri AK, Hackley VA.

Chem Mater. 2011 May 24;23(10):2665-2676.

18.

Lipid component quantitation by thin layer chromatography.

Clogston JD, Patri AK.

Methods Mol Biol. 2011;697:109-17. doi: 10.1007/978-1-60327-198-1_11.

PMID:
21116959
19.

Detecting and measuring free gadolinium in nanoparticles for MRI imaging.

Clogston JD, Patri AK.

Methods Mol Biol. 2011;697:101-8. doi: 10.1007/978-1-60327-198-1_10.

PMID:
21116958
20.

SEM X-ray microanalysis of nanoparticles present in tissue or cultured cell thin sections.

Zheng J, Nagashima K, Parmiter D, de la Cruz J, Patri AK.

Methods Mol Biol. 2011;697:93-9. doi: 10.1007/978-1-60327-198-1_9.

PMID:
21116957
21.

Biological tissue and cell culture specimen preparation for TEM nanoparticle characterization.

Nagashima K, Zheng J, Parmiter D, Patri AK.

Methods Mol Biol. 2011;697:83-91. doi: 10.1007/978-1-60327-198-1_8.

PMID:
21116956
22.

Zeta potential measurement.

Clogston JD, Patri AK.

Methods Mol Biol. 2011;697:63-70. doi: 10.1007/978-1-60327-198-1_6.

PMID:
21116954
23.

Characterization of nanoparticles by matrix assisted laser desorption ionization time-of-flight mass spectrometry.

Ramalinga U, Clogston JD, Patri AK, Simpson JT.

Methods Mol Biol. 2011;697:53-61. doi: 10.1007/978-1-60327-198-1_5.

PMID:
21116953
24.

Chromatographic methods for the quantification of free and chelated gadolinium species in MRI contrast agent formulations.

Cleveland D, Long SE, Sander LC, Davis WC, Murphy KE, Case RJ, Rimmer CA, Francini L, Patri AK.

Anal Bioanal Chem. 2010 Dec;398(7-8):2987-95. doi: 10.1007/s00216-010-4226-2. Epub 2010 Oct 3.

PMID:
20890749
25.

A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer.

Ahn RW, Chen F, Chen H, Stern ST, Clogston JD, Patri AK, Raja MR, Swindell EP, Parimi V, Cryns VL, O'Halloran TV.

Clin Cancer Res. 2010 Jul 15;16(14):3607-17. doi: 10.1158/1078-0432.CCR-10-0068. Epub 2010 Jun 2.

26.

Biological assessment of triazine dendrimer: toxicological profiles, solution behavior, biodistribution, drug release and efficacy in a PEGylated, paclitaxel construct.

Lo ST, Stern S, Clogston JD, Zheng J, Adiseshaiah PP, Dobrovolskaia M, Lim J, Patri AK, Sun X, Simanek EE.

Mol Pharm. 2010 Aug 2;7(4):993-1006. doi: 10.1021/mp100104x.

27.

Lack of significant dermal penetration of titanium dioxide from sunscreen formulations containing nano- and submicron-size TiO2 particles.

Sadrieh N, Wokovich AM, Gopee NV, Zheng J, Haines D, Parmiter D, Siitonen PH, Cozart CR, Patri AK, McNeil SE, Howard PC, Doub WH, Buhse LF.

Toxicol Sci. 2010 May;115(1):156-66. doi: 10.1093/toxsci/kfq041. Epub 2010 Feb 15.

28.

Detoxification of gold nanorods by treatment with polystyrenesulfonate.

Leonov AP, Zheng J, Clogston JD, Stern ST, Patri AK, Wei A.

ACS Nano. 2008 Dec 23;2(12):2481-8. doi: 10.1021/nn800466c.

29.

Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.

Dobrovolskaia MA, Patri AK, Zheng J, Clogston JD, Ayub N, Aggarwal P, Neun BW, Hall JB, McNeil SE.

Nanomedicine. 2009 Jun;5(2):106-17. doi: 10.1016/j.nano.2008.08.001. Epub 2008 Dec 13.

30.

HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents.

Puri A, Kramer-Marek G, Campbell-Massa R, Yavlovich A, Tele SC, Lee SB, Clogston JD, Patri AK, Blumenthal R, Capala J.

J Liposome Res. 2008;18(4):293-307. doi: 10.1080/08982100802457377 .

31.

Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement.

Swanson SD, Kukowska-Latallo JF, Patri AK, Chen C, Ge S, Cao Z, Kotlyar A, East AT, Baker JR.

Int J Nanomedicine. 2008;3(2):201-10.

32.

Biodistribution of nanomedicines.

Simanek E, Patri AK.

Mol Pharm. 2008 Jul-Aug;5(4):473. doi: 10.1021/mp800083a. No abstract available.

PMID:
18672948
33.

Method for analysis of nanoparticle hemolytic properties in vitro.

Dobrovolskaia MA, Clogston JD, Neun BW, Hall JB, Patri AK, McNeil SE.

Nano Lett. 2008 Aug;8(8):2180-7. doi: 10.1021/nl0805615. Epub 2008 Jul 8.

34.

Adverse effects of fullerenes on endothelial cells: fullerenol C60(OH)24 induced tissue factor and ICAM-I membrane expression and apoptosis in vitro.

Gelderman MP, Simakova O, Clogston JD, Patri AK, Siddiqui SF, Vostal AC, Simak J.

Int J Nanomedicine. 2008;3(1):59-68.

35.

Characterization of nanoparticles for therapeutics.

Hall JB, Dobrovolskaia MA, Patri AK, McNeil SE.

Nanomedicine (Lond). 2007 Dec;2(6):789-803. Review.

PMID:
18095846
36.

Dendrimer-based BH3 conjugate that targets human carcinoma cells.

Myc A, Patri AK, Baker JR Jr.

Biomacromolecules. 2007 Oct;8(10):2986-9. Epub 2007 Sep 18.

PMID:
17877400
37.

Analysis of fullerene-based nanomaterial in serum matrix by CE.

Chan KC, Patri AK, Veenstra TD, McNeil SE, Issaq HJ.

Electrophoresis. 2007 May;28(10):1518-24.

PMID:
17447247
38.

HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.

Shukla R, Thomas TP, Peters JL, Desai AM, Kukowska-Latallo J, Patri AK, Kotlyar A, Baker JR Jr.

Bioconjug Chem. 2006 Sep-Oct;17(5):1109-15.

PMID:
16984117
39.

Molecular heterogeneity analysis of poly(amidoamine) dendrimer-based mono- and multifunctional nanodevices by capillary electrophoresis.

Shi X, Majoros IJ, Patri AK, Bi X, Islam MT, Desai A, Ganser TR, Baker JR Jr.

Analyst. 2006 Mar;131(3):374-81. Epub 2006 Jan 18.

PMID:
16496045
40.

Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.

Patri AK, Kukowska-Latallo JF, Baker JR Jr.

Adv Drug Deliv Rev. 2005 Dec 14;57(15):2203-14. Epub 2005 Nov 14.

PMID:
16290254
41.

Lipid bilayer disruption by polycationic polymers: the roles of size and chemical functional group.

Mecke A, Majoros IJ, Patri AK, Baker JR Jr, Holl MM, Orr BG.

Langmuir. 2005 Nov 8;21(23):10348-54.

PMID:
16262291
42.

Analysis of poly(amidoamine)-succinamic acid dendrimers by slab-gel electrophoresis and capillary zone electrophoresis.

Shi X, Patri AK, Lesniak W, Islam MT, Zhang C, Baker JR Jr, Balogh LP.

Electrophoresis. 2005 Aug;26(15):2960-7.

PMID:
16007703
43.

Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy.

Patri AK, Myc A, Beals J, Thomas TP, Bander NH, Baker JR Jr.

Bioconjug Chem. 2004 Nov-Dec;15(6):1174-81.

PMID:
15546182
44.

In vitro targeting of synthesized antibody-conjugated dendrimer nanoparticles.

Thomas TP, Patri AK, Myc A, Myaing MT, Ye JY, Norris TB, Baker JR Jr.

Biomacromolecules. 2004 Nov-Dec;5(6):2269-74.

PMID:
15530041
45.

Detection and analysis of tumor fluorescence using a two-photon optical fiber probe.

Thomas TP, Myaing MT, Ye JY, Candido K, Kotlyar A, Beals J, Cao P, Keszler B, Patri AK, Norris TB, Baker JR Jr.

Biophys J. 2004 Jun;86(6):3959-65.

46.

Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor.

Quintana A, Raczka E, Piehler L, Lee I, Myc A, Majoros I, Patri AK, Thomas T, Mulé J, Baker JR Jr.

Pharm Res. 2002 Sep;19(9):1310-6.

47.

Dendritic polymer macromolecular carriers for drug delivery.

Patri AK, Majoros IJ, Baker JR.

Curr Opin Chem Biol. 2002 Aug;6(4):466-71. Review.

PMID:
12133722
48.

Synthesis of Unsymmetrical 5,5'-Disubstituted 2,2'-Bipyridines(1).

Newkome GR, Gross J, Patri AK.

J Org Chem. 1997 May 2;62(9):3013-3014. No abstract available.

PMID:
11671670

Supplemental Content

Loading ...
Support Center